Position in AZN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$74,900,656
-$6,111,598 QoQ
Shares Held
395,004
-3.8% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#141
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Compagnie Lombard Odier SCmA holds $723,906,825 across 10 Drug Manufacturers - General names. AZN ranks #4 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
258,737 | $310,336,944 | |
| 2 | MRK |
Merck & Co., Inc.
|
790,796 | $101,617,285 | |
| 3 | JNJ |
Johnson & Johnson
|
375,199 | $95,289,289 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
395,004 | $74,900,656 | |
| 5 | ABBV |
AbbVie Inc.
|
276,074 | $69,471,261 | |
| 6 | AMGN |
Amgen Inc
|
171,214 | $62,000,013 | |
| 7 | PFE |
Pfizer Inc
|
382,649 | $9,214,187 | |
| 8 | NVO |
Novo Nordisk A S
|
20,029 | $960,190 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,900,656 | 395,004 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $81,012,254 | 410,771 | Shares | Defined | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||